Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for Children With Tourette Syndrome
NCT01172288Phase 2Completed
- Sponsor
- Yale University
- Start
- Jul 2010
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Tourette syndrome (TS) and chronic tic disorder comparing N-Acetylcysteine with Placebo (2 arms). Primary endpoint: Improvement in Tic Severity at 12 weeks. Started Jul 2010; status: completed.
02
Drugs
acetylcysteine
03
Conditions
Tourette syndrome (TS)chronic tic disorder
Beyond the preview
Go deeper on NCT01172288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01172288.